🟢 Moleculin Biotech is trading 6.24% up in pre-market with no confirmed catalyst identified

Moleculin Biotech is trading 6.24% up in pre-market at $0.63 after no confirmed company-specific announcement was identified for August 24, 2026.

• The latest update, released August 14, covered second-quarter results and continued MIRACLE trial progress, including a planned September enrollment milestone.
• That information appears stale for this pre-market move.
• Broader indices are lower, so market-wide sentiment does not clearly explain the gain.